This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Pfizer Corporation. Active years: 2019-2021.
Company Filing History:
Years Active: 2019-2021
Title: Innovations in Cancer Vaccines by Derek John Falconer
Introduction
Derek John Falconer is a notable inventor based in San Diego, CA. He has made significant contributions to the field of cancer research, particularly in the development of innovative cancer vaccines. With a total of 2 patents, Falconer's work is paving the way for advancements in immunotherapy.
Latest Patents
Falconer's latest patents focus on cancer vaccines. The present disclosure provides isolated immunogenic TAA polypeptides, including immunogenic MUC1 polypeptides, immunogenic MSLN polypeptides, and immunogenic TERT polypeptides. Additionally, it includes isolated nucleic acid molecules encoding one or more immunogenic TAA polypeptides. The compositions comprise an immunogenic TAA polypeptide or an isolated nucleic acid molecule encoding an immunogenic TAA polypeptide. Furthermore, the patents detail methods relating to the uses of the polypeptides, nucleic acid molecules, and compositions.
Career Highlights
Derek John Falconer is currently associated with Pfizer Corporation, where he continues to innovate in the field of cancer treatment. His work is instrumental in advancing the understanding and application of cancer vaccines.
Collaborations
Falconer has collaborated with notable colleagues, including Marianne Marcela Andrea Martinic and Joseph John Binder. Their combined expertise contributes to the success of their research initiatives.
Conclusion
Derek John Falconer's contributions to cancer vaccine development highlight his role as a leading inventor in the field. His innovative approaches and collaborations are essential for the future of cancer treatment.